Survodutide

What Is Survodutide?
Survodutide is an investigational peptide engineered to activate both glucagon and glucagon-like peptide-1 (GLP-1) receptors. Researchers have investigated this dual mechanism for its potential influence on metabolic physiology, energy regulation, and liver-related pathways.
Clinical development remains ongoing, and current evidence is based on Phase II clinical trials together with continuing research evaluating long-term safety and efficacy. (Loomba R. et al., The Lancet Diabetes & Endocrinology, 2024.)
.avif)
.avif)
Current Research
Research involving survodutide has focused on metabolic regulation, liver health, and dual hormone receptor biology.
Other Peptides
Any Questions?

Our Happy Clients



A Smarter Way to Source and Save
RPN helps aesthetic and medical clinics reduce costs on injectable weight loss products through a streamlined, plug-and-play purchasing system. Our platform is designed to simplify sourcing, improve efficiency, and support clinics as they grow.
By connecting providers with better pricing opportunities, we make it easier to operate smarter without disrupting existing workflows.
Save With RPN
Take the first step with a free cost analysis tailored to your clinic. Our team will review your current purchasing approach and identify opportunities to reduce expenses and improve efficiency. From there, you can seamlessly schedule a discovery call to explore how RPN fits into your workflow.


.jpg)
.jpg)
.jpg)